STUB1 and myelodysplastic syndrome: The accumulation of somatic cancer-associated mutations in HSCs, as observed in CHIP, enhances the risk of developing a hematologic neoplasm such as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML).